TrialInvestigational new drugs2021

Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trial.

M Mego et al.PubMed ↗Publisher ↗

No numbers read from the abstract.